Table 3 Association between ISX rs5755368 polymorphism and colorectal cancer risk.
ISX rs5755368 | Controls | Cases | Model 1 | Model 2 | ||||
|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-valuea | OR | 95% CI | p-valuea | |||
GG | 22 (2.7) | 27 (4.5) | 1.00 | 1.00 | ||||
AG | 258 (31.5) | 215 (35.8) | 0.68 | 0.38–1.23 | 0.199 | 0.70 | 0.34–1.47 | 0.352 |
AA | 539 (65.8) | 358 (59.7) | 0.54 | 0.30–0.97 | 0.038 | 0.55 | 0.27–1.14 | 0.108 |
Dominant | ||||||||
AG + GG | 280 (34.2) | 242 (40.3) | 1.00 | 1.00 | ||||
AA | 539 (65.8) | 358 (59.7) | 0.77 | 0.62–0.96 | 0.018 | 0.76 | 0.58–0.99 | 0.045 |
Recessive | ||||||||
GG | 22 (2.7) | 27 (4.5) | 1.00 | 1.00 | ||||
AA + AG | 797 (97.3) | 573 (95.5) | 0.59 | 0.33–1.04 | 0.067 | 0.60 | 0.29–1.24 | 0.168 |